Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by CHECKMATE77 on Jan 05, 2017 10:11am

Donnatal

I posted this maybe 2 yrs ago
donnatal was sold in Canada back in the 70's
taken off the mkt because
1- ineffective
2- contained a barbiturate which is addicting and causes sedation

how can one invest in any company that has such a large part of its revenue
on this lousy medication
thats all
Comment by Rookie89 on Jan 05, 2017 10:35am
Shut the f up. You didn't say anything for last few days when it was going up now it turned red today you post right away.
Comment by DeathPool on Jan 05, 2017 10:46am
So then what you are suggesting to CHECKMATE that there is only a window that one can post?  Loooollll !!!   I live for loasahs llike you who try and shut up the free flow of information.   There is and will be volatility in this stock and if one wants to play a 10 penny pump up or 10 penny short deal with it champ.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities